NCT ID: NCT06866483
Study Summary
This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to seek medical evaluation for suspected myasthenia gravis (MG).
Eligibility Requirements
Inclusion Criteria: * Reside within the 50 states of the United States at the time of enrollment * Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state * Active email account * Fluency in English (spoken / written), as demonstrated by the ability to read and sign the Informed Consent Form Exclusion Criteria: * Live in an overseas territory of the United States * Inability or unwillingness to provide written informed consent * Diagnosed myasthenia gravis, including sero-negative MG* * Diagnosed multiple sclerosis * Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke
View full study details and apply: https://clinicaltrials.gov/study/NCT06866483
